Simoctocog Alfa
Products Simoctocog alfa was approved in the EU in 2014 and in many countries in 2016 as a powder and solvent for the preparation of a [solution for injection>injections] (Nuwiq). Structure and properties Simoctocog alfa is a variant of blood clotting factor VIII lacking the B domain of the protein. The sequence is comparable to … Simoctocog Alfa
